NextPoint Therapeutics, Inc.
Emma Aeschliman is a skilled research associate currently employed at NextPoint Therapeutics, Inc. since January 2023. Prior experience includes a position as Research Associate 1 at Thunder Biotech from October 2021 to December 2022, and a role as a Quality Laboratory Technician and Document Specialist at Elevate Health Sciences in mid-2021. Emma began a professional career in customer service as a representative for Frontline Pest Professionals from June 2018 to August 2021 and briefly worked as a caregiver at Caretel Inns Of Brighton in 2017. Emma holds a degree in Microbiology from Brigham Young University, completed in 2021.
NextPoint Therapeutics, Inc.
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.